HYPD Stock Analysis: Buy, Sell, or Hold?
HYPD - Hyperion DeFi, Inc. Common Stock
$3.14
0.00 (0.00%)
▲
5d:
-7.65%
30d:
-18.65%
90d:
-8.99%
HOLD
LOW Confidence
Analysis Updated: Jul 1, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When HYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HYPD is fairly valued with market pricing in 0.6% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: HYPD is fairly valued with market pricing in 0.6% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.89
Based on -20.0% avg growth
INTRINSIC VALUE TODAY
$0.56
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HYPD is currently trading at $3.14, which is considered slightly low relative to its 30-day fair value range of $2.94 to $3.74. The stock's valuation (Forward PE: 7.1) is in line with its historical norms (6.9). At these levels, the market is pricing in 0.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HYPD is showing sideways momentum. Immediate support is located at $2.56, while resistance sits at $4.05.
Market Sentiment: HYPD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.65 (+79.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HYPD is showing sideways momentum. Immediate support is located at $2.56, while resistance sits at $4.05.
Market Sentiment: HYPD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.65 (+79.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.94 -
$3.74
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
91.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 79.9% below Wall St target ($5.65)
- NEUTRAL: Market pricing in 0.6% annual earnings growth - fairly valued
- CAUTION: Recommendation downgraded due to -7.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$2.94 -
$3.74
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.56
Resistance Level
$4.05
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.06
Wall Street Target
$5.65
(+79.9%)
Revenue Growth (YoY)
1559.5%
Valuation Premium vs History
+0.6% premium
PE vs Historical
7.1 vs 6.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$3.16
(+1%)
2-Year Target
$3.18
(+1%)
3-Year Target
$3.20
(+2%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
PE COMPRESSION
$3.13
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -44.0%)
$7.07
(+125%)
Base:
(SPY PE: 7.1, Growth: -44.0%)
$2.29
(-27%)
Bear:
(PE: 6.0, Growth: -44.0%)
$1.95
(-38%)
Share & Embed Analysis
Last updated: July 02, 2026 12:45 AM ET
Data refreshes hourly during market hours. Next update: 1:45 AM
Data refreshes hourly during market hours. Next update: 1:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 62 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 61 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 63 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
